PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells
Laura Codarri Deak(Roche (Switzerland)), Pablo Umaña(Roche (Switzerland))
Cited by 257
Related Papers
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
|Clinical Cancer Research|2021|62
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
|Journal for ImmunoTherapy of Cancer|2022|24